Menu

Best full-body 1.5T and 3T MRI access

3T MRI has advantages over 1.5T for several conditions and applications1:

  • Breast cancer
  • Brain tumor
  • Stroke and lesions
  • Heart diseases
  • Vascular identification
  • Prostate cancer
  • Musculoskeletal conditions

Intellis™ Pro patients can now access
95%
of MRI scanners2 vs. 68% with 1.5T only.†

Icon: MRI

Best full-body 1.5T and 3T MRI access† with impedance independence

Icon: multiple waveform

Multiple waveform options allowing flexible patient programming

Icon: smallest and thinnest

Smallest and thinnest 
designed for comfort

Intellis™ Pro spinal cord stimulation system

Intellis™ Pro continues to offer: 

  • Superior back pain relief with DTM SCS3
  • AdaptiveStim™ technology
  • Proprietary Overdrive™ battery technology‡

Impedance independence

MRI access at five-year follow-up

An independent study found that, at five years, 43% of Abbott, Boston Scientific, and Nevro patients lost their ability to undergo a scan due to high electrode impedance.4


Medtronic SureScan™
100%


Abbott, Boston Scientific, Nevro4 
57%

Only Medtronic SCS systems offers unimpeded MRI access†

  Medtronic†,5 Biotronik6 Boston Scientific7,8 Saluda9 Nevro10 Abbott11,12
Able to scan high impedance or fractured lead ✔ ✕ ✕ ✕ ✕ ✕
Able to scan fully discharged device ✔ ✕ ✕ ✕ ✕ ✕
1.5T full body normal operating mode with every lead in the portfolio​ ✔ ✔ ✕ ✕ ✕ ✕
3T full-body ✔ ✔ ✕ ✕ ✕ ✕
Able to scan patient in prone position e.g., breast MR ✔ ✔ ✔ ✔ ✔ ✕


✔ Proceed with full-body MRI scan
✕ Does not meet criteria

Purposeful engineering for MRI 

Only Medtronic has protective lead shielding that dissipates RF energy and allows out-of-range electrode impedances to be scanned safely.

SureScan™ MRI tantalum RF shielding

The shielded lead reduces the risk of thermal tissue damage.

The SureScan™ lead allows MRI scans, enabling diagnostic care.

Multiple waveform options allowing flexible patient programming

Built on the latest SCS platform, Intellis™ Pro introduces new programming features for enhanced flexibility over the previous generation device.

  • Eight independent groups for therapy personalization
  • Enhanced cycling capability

Patients now have a wider range of treatment options at their fingertips, enabling them to easily switch based on their changing preferences.

A man sitting in a chair checks his cell phone.

Superior pain relief proven across multiple RCTs3,14

Decades of basic science research led up to the creation of Differential Target Multiplexed™ spinal cord stimulation (SCS). DTM™ SCS was inspired by preclinical research demonstrating that DTM™ waveform can differentially modulate neurons and glial cells to balance interactions perturbed by neuropathic pain.3,16,17
 

  • DTM™ RCT3: Low back and leg pain, 94 implanted patients
  • NOVA RCT14: Low back and leg pain, 77 implanted patients
  • PROCURA single arm study14: Upper limb pain, 46 implanted patients

DTM™ SCS has been demonstrated to provide over
84%
responder rate in multiple studies including two RCTs.


84%
  

91%
  

86%

DTM™ RCT
(back pain)3
NOVA RCT for patients not eligible for spine surgery with degenerative disc disease (DDD), herniated disc (HD), or radicular pain syndrome (RPS) (back and leg pain)15
PROCURA
(upper limb pain)15